{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:30:09Z","timestamp":1792164609642,"version":"4.4.0"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1721,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1468-1331.2010.03276.x","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T14:16:40Z","timestamp":1292422600000},"page":"e43-e44","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of zonisamide in a case of Parkinson\u2019s disease with intractable resting and re-emergent tremor"],"prefix":"10.1111","volume":"18","author":[{"given":"M.","family":"Iijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,15]]},"reference":[{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0168-0102(01)00298-X","article-title":"Zonisamide has beneficial effects on Parkinson\u2019s disease patients","volume":"41","author":"Murata","year":"2001","journal-title":"Neurosci Res"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2174\/1381612043453180","article-title":"Nobel therapeutic effects of the anti-convulsant, zonisamide on Parkinson\u2019s disease","volume":"10","author":"Murata","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","article-title":"Zonisamide improves motor function in Parkinson\u2019s disease: a randomized, double-blind study","volume":"68","author":"Murata","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00702-004-0107-1","article-title":"Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson\u2019s activity","volume":"111","author":"Gluck","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB5|cit5","first-page":"685","article-title":"Effect of zonisamide on resting tremor resistant to antiparkinsonian medication","volume":"55","author":"Nakanishi","year":"2003","journal-title":"No to Shinkei"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/mds.21717","article-title":"Zonisamide in patients with essential tremor and Parkinson\u2019s disease","volume":"22","author":"Bermejo","year":"2007","journal-title":"Mov Disord"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2004.09.004","article-title":"Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol","volume":"11","author":"Morita","year":"2005","journal-title":"Parkinsonism Related Disord"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11940-006-0016-8","article-title":"Essential tremor: treatment options","volume":"8","author":"Ondo","year":"2006","journal-title":"Curr Treat Opt Neurol"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mds.21282","article-title":"A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor","volume":"22","author":"Zesiewicz","year":"2007","journal-title":"Mov Disord"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2007.05.008","article-title":"Effects of zonisamide on experimental tremors in rats","volume":"14","author":"Miwa","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.parkreldis.2008.02.008","article-title":"Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect","volume":"15","author":"Miwa","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/jnnp.67.5.646","article-title":"Re-emergent tremor of Parkinson\u2019s disease","volume":"67","author":"Jankovic","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0920-1211(95)00078-X","article-title":"Effects of zonisamide on dopaminergic system","volume":"22","author":"Okada","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0920-1211(92)90066-3","article-title":"Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2\u2003+\u2003 dependent dopamine release","volume":"13","author":"Okada","year":"1992","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1468-1331.2010.03276.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neures.2007.10.002","article-title":"Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinine formation","volume":"60","author":"Asanuma","year":"2008","journal-title":"Neurosci Res"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2010.03276.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1468-1331.2010.03276.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T21:36:39Z","timestamp":1625520999000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2010.03276.x"}},"subtitle":["Letter to Editor"],"short-title":[],"issued":{"date-parts":[[2010,12,15]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03276.x","relation":{},"ISSN":["1351-5101"],"issn-type":[{"value":"1351-5101","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,15]]}}}